epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Aplenzin
    bupropion hydrobromide
  • remove Esgic-Plus
    butalbital/ acetaminophen/ caffeine
  • remove Moxeza
    moxifloxacin ophthalmic
  • remove Vicks Sinex Severe Nasal Spray
    oxymetazoline nasal

multicheck MultiCheck Results - 4 Interactions

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Aplenzin (bupropion hydrobromide) + Esgic-Plus (butalbital/ acetaminophen/ caffeine)

Monitor/Modify Tx


bupropion + caffeine

monitor BP; avoid excessive caffeine intake: combo may incr. risk of HTN (additive effects)

Caution Advised


bupropion + butalbital

caution advised: combo may decr. bupropion and metabolite levels, efficacy (hepatic metabolism induced)

Smiley face Smiley face Aplenzin (bupropion hydrobromide) + Vicks Sinex Severe Nasal Spray (oxymetazoline nasal)

Monitor/Modify Tx


bupropion + oxymetazoline nasal

monitor BP: combo may incr. risk of HTN (additive effects)

Smiley face Smiley face Esgic-Plus (butalbital/ acetaminophen/ caffeine) + Vicks Sinex Severe Nasal Spray (oxymetazoline nasal)

Monitor/Modify Tx


caffeine + oxymetazoline nasal

monitor BP; avoid excessive caffeine intake: combo may incr. risk of HTN (additive effects)

Additional Considerations

Smiley face Smiley face bupropion in Aplenzin

caution advised with concomitant drugs if smoking cessation use; dose adjustments may be necessary; smoking cessation may alter pharmacokinetics or pharmacodynamics of certain drugs

add MAO inhibitor to Interaction Check if recent (14 days) use

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information